CoreCap Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CoreCap Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$203K	Buy	1,289 +49	+4%	+$7.74K	0.01%	836
2026 Q2	$196K	Sell	1,240 -359	-22%	-$48.5K	0.01%	869
2026 Q1	$204K	Sell	1,599 -64	-4%	-$7.99K	0.01%	796
2025 Q4	$203K	Buy	1,663 +616	+59%	+$70.6K	0.01%	792
2025 Q3	$105K	Hold	1,047	–	–	﹤0.01%	1016
2025 Q2	$86.8K	Hold	1,047	–	–	﹤0.01%	1036
2025 Q1	$84.9K	Sell	1,047 -115	-10%	-$10.3K	﹤0.01%	962
2024 Q4	$105K	Sell	1,162 -300	-21%	-$29.1K	﹤0.01%	912
2024 Q3	$144K	Hold	1,462	–	–	0.01%	786
2024 Q2	$136K	Hold	1,462	–	–	0.01%	435
2024 Q1	$139K	Buy	+1,462	New	+$136K	0.01%	731
2022 Q4	$176K	Buy	+2,126	New	+$172K	0.01%	570
2022 Q3	–	Sell	-2,217	Closed	-$165K	–	2130
2022 Q2	$165K	Buy	+2,217	New	+$166K	0.01%	565
2022 Q1	–	Sell	-2,126	Closed	-$238K	–	2126
2021 Q4	$238K	Buy	+2,126	New	+$256K	0.02%	497

Other funds holding XBI

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC. New York $3.57B AUM 26.72% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Parkway Wealth Management Plano, Texas $869M AUM 25.74% 1-Year Est. Return

Weatherly Asset Management Del Mar, California $1.42B AUM 33.31% 1-Year Est. Return

L. Roy Papp & Associates Phoenix, Arizona $981M AUM 26.21% 1-Year Est. Return

Royal Fund Management Lady Lake, Florida $1.26B AUM 23.83% 1-Year Est. Return

Edge Wealth Management New York $666M AUM 17.64% 1-Year Est. Return

Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return

CoreCap Advisors's XBI Position: Q3 2026 in Review

CoreCap Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 4% in Q3 2026, buying an estimated $7.74K and bringing the position to 1,289 shares worth $203K. The position accounts for 0.01% of the portfolio, ranked #836.

CoreCap Advisors first reported a position in XBI in Q4 2021 and has held it in 14 quarters since. The position peaked at $238K in Q4 2021. 235 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

CoreCap Advisors held 1,289 shares of State Street SPDR S&P Biotech ETF worth $203K as of Q3 2026.
CoreCap Advisors bought 49 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $7.74K.
State Street SPDR S&P Biotech ETF made up 0.01% of CoreCap Advisors's portfolio in Q3 2026, its #836 holding.
CoreCap Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 14 quarters since.
CoreCap Advisors's State Street SPDR S&P Biotech ETF position peaked at $238K in Q4 2021.
235 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.